Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 09:05:28 06/06/2024 pm IST After market 09:50:21 pm
171.9 EUR +0.67% Intraday chart for Merck KGaA 172 +0.07%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Merck KGaA Completes EUR180 Million German Distribution Center Expansion MT
Merck Opens Newly Expanded Life Science Distribution Center in Schnelldorf, Germany CI
High price target from HSBC drives Merck KGaA up DP
Global markets live: ASML, Intel, Microsoft, Tesla, J&J, Gitlab Our Logo
MERCK KGAA : JP Morgan remains its Buy rating ZD
MERCK KGAA : Barclays keeps its Buy rating ZD
Merck KGaA to Launch New Clinical Studies for Oncology Pipeline MT
Merck KGaA Provides Updates on the Oncology Pipeline and Focused Approach to the Research and Development of Potential New Medicines Designed to Improve the Futures of Cancer Treatment CI
Transcript : Merck KGaA - Special Call
MERCK KGAA : Buy rating from JP Morgan ZD
Merck KGaA: memorandum of understanding with South Korean institute CF
Merck KGaA Signs Korea Science Research Pact DJ
Merck KGaA Teams up With South Korean University to Support Life Sciences Research MT
MERCK KGAA : Jefferies reaffirms its Buy rating ZD
MERCK : A lower starting point for future growth Alphavalue
MERCK KGAA : Receives a Buy rating from UBS ZD
Merck KGaA: acquisition of U.S.-based Mirus Bio CF
Merck KGaA Buys Mirus Bio for $600 Million DJ
Merck to Buy Mirus Bio for $600 Million MT
MERCK KGAA : DZ Bank gives a Buy rating ZD
MERCK KGAA : Gets a Buy rating from Barclays ZD
EU GDP Estimates, Rosy Spring Forecast Prop Up German Stocks MT
MERCK : Electronics came as a big surprise Alphavalue
Transcript : Merck KGaA, Q1 2024 Earnings Call, May 15, 2024
UBS rates Merck KGaA a 'Buy' - Target 186 euros DP
Chart Merck KGaA
More charts
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
170.8 EUR
Average target price
186.1 EUR
Spread / Average Target
+8.97%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck KGaA
  5. Merck KGaA Opens Expanded Production Facility in Wisconsin, US